1. Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial. Issue 10 (October 2015) Authors: Lalezari, Jacob P; Latiff, Gulam H; Brinson, Cynthia; Echevarría, Juan; Treviño-Pérez, Sandra; Bogner, Johannes R; Thompson, Melanie; Fourie, Jan; Sussmann Pena, Otto A; Mendo Urbina, Fernando C; Martins, Marcelo; Diaconescu, Iulian G; Stock, David A; Joshi, Samit R; Hanna, George J; Lataillade, Max Journal: Lancet Issue: Volume 2:Issue 10(2015) Page Start: e427 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗